Anti-PD-1 scFv h(FcεRIγ) CART, pCDCAR1

  • 1.00 Dollar US$
  • Published date: February 8, 2018
    • Shirley, New York, United States

https://www.creative-biolabs.com/car-t/pcdcar1-pd-1-h-fcεriγ-t-468.htm The vector of anti-PD-1 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PD-1. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-PD-1 antibody linked to FcεRIγ signaling domains. And the vector product was designed for the treatment of B-cell malignancies.

Result 0 votes
Bella
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-PD-1 scFv h(CD28) CART, pCDCAR1

    Anti-PD-1 scFv h(CD28) CART, pCDCAR1

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-pd-1-h-28-t-467.htm The vector of anti-PD-1 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PD-1. The T cells are genetically modified through transduction w...

  • Human anti-AURKA T cell receptor, pSFG

    Human anti-AURKA T cell receptor, pSFG

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/anti-aurka-tcr-psfg-590.htm The vector of anti-AURKA T cell receptor (TCR) is constructed for the engineering of T cell to target Human AURKA. The T cells are genetically modified through transduction with a ret...

  • Anti-CD22 scFv h(CD28) CART, pCDCAR1

    Anti-CD22 scFv h(CD28) CART, pCDCAR1

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/car-t/pcdcar1-cd22-h-28-t-97.htm The vector of anti-CD22 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD22. The T cells are genetically modified through transduction wi...